| 11845730 |
1,3-substituted cyclobutyl derivatives and uses thereof |
Donglei Liu, Julien Papillon, Stefan Peukert |
2023-12-19 |
|
| 10550102 |
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators |
Christopher M. Adams, Doug Bevan, Michael Paul Capparelli, Takeru Ehara, Luciana Ferrara +6 more |
2020-02-04 |
$32,167,000 |
| 10208018 |
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators |
Christopher M. Adams, Doug Bevan, Michael Paul Capparelli, Takeru Ehara, Luciana Ferrara +6 more |
2019-02-19 |
$29,603,000 |
| 9957254 |
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators |
Christopher M. Adams, David B. Belanger, Doug Bevan, Philippe Bolduc, Takeru Ehara +6 more |
2018-05-01 |
$22,217,000 |
| 9765067 |
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators |
Christopher M. Adams, David B. Belanger, Doug Bevan, Takeru Ehara, Luciana Ferrara +6 more |
2017-09-19 |
$6,551,000 |
| 9676728 |
2-benzyl-benzimidazole complement factor B inhibitors and uses thereof |
Christopher M. Adams, Takeru Ehara, Keith Jendza, Nan Ji, Rajeshri Ganesh Karki +4 more |
2017-06-13 |
$14,193,000 |
| 9475806 |
Complement factor B inhibitors and uses there of |
Christopher M. Adams, Charles BABU, Michael Paul Capparelli, Jian Ding, Takeru Ehara +8 more |
2016-10-25 |
$8,179,000 |
| 9056874 |
Complement pathway modulators and uses thereof |
Christopher M. Adams, Charles BABU, Michael Paul Capparelli, Jian Ding, Takeru Ehara +8 more |
2015-06-16 |
$16,215,000 |
| 8541432 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2013-09-24 |
$12,483,000 |
| 8501756 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2013-08-06 |
$7,772,000 |
| 8492393 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2013-07-23 |
$11,073,000 |
| 8486954 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2013-07-16 |
$10,683,000 |
| 8431584 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2013-04-30 |
$5,595,000 |
| 8242125 |
Heterobicyclic carboxamides as inhibitors for kinases |
Gerald D. Artman, III, Jason Matthew Elliott, Nan Ji, Donglei Liu, Fupeng Ma +4 more |
2012-08-14 |
$12,923,000 |
